Monoclonal antibody radiopharmaceuticals: Cationization, pegylation, radiometal chelation, pharmacokinetics, and tumor imaging

Bioconjugate Chemistry

Volumn 14, Issue 3, 2003, Pages 546-553

  Lee, Hwa Jeong ^a,b   Pardridge, William M ^a,b,c  

^a Ewha Womans University   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROPHORESIS; MAMMALS; PHARMACOKINETICS; POLYETHYLENE GLYCOLS; RADIOGRAPHY; TUMORS;

CATIONIZATION; CATIONIZED; DIETHYLENETRIAMINE PENTA-ACETIC ACIDS; EPIDERMAL GROWTH FACTOR RECEPTORS; HUMAN EPIDERMAL GROWTH FACTOR; MURINE MONOCLONAL ANTIBODY; PEGYLATED; PEGYLATION; PHARMACOKINETIC ANALYSIS; TUMOR IMAGING;

MONOCLONAL ANTIBODIES;

1,6 HEXANEDIAMINE; EPIDERMAL GROWTH FACTOR RECEPTOR; INDIUM 111; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 528; PENTETIC ACID; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CHELATION; DRUG DISTRIBUTION; ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMUNORADIOMETRIC ASSAY; ISOELECTRIC FOCUSING; MOUSE; NONHUMAN;

ANIMALIA; MURINAE;

EID: 0037908924     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0256648     Document Type: Article

References (17)

1. Vriesendorp, H. M., and Quadri, S. M. (2001) Radiolabeled immunoglobulin therapy: Old barriers and new opportunities. Expert Rev. Anticancer Ther. 1, 461-478.
2. Triguero, D., Buciak, J. B., Yang, J., and Pardridge, W. M. (1989) Blood-brain barrier transport of cationized immunoglobulin G: Enhanced delivery compared to native protein. Proc. Natl. Acad. Sci. 86, 4761-4765.
3. Basu, S. K., Goldstein, J. L., Anderson, R. G. W., and Brown, M. S., (1976) Degradation of cationized low-density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 73, 1378-3182.
4. Shen, W.-C. and Ryser, H. J.-P. (1978) Conjugation of polyL-lysine to albumin and horseradish peroxidase: A novel method of enhancing the cellular uptake of proteins. Proc. Natl. Acad. Sci. U.S.A. 75, 1872-1876.
5. Vorbrodt, A. W. (1989) Ultracytochemical characterization of anionic sites in the wall of brain capillaries. J. Neurocytol. 18, 359-368.
6. Riabowol, K. T., Vosatka, R. J., Ziff, E. B., Lamb, N. J., and Feramisco, J. R. (1998) Microinjection of fos-specific antiboides blocks DNA synthesis in fibroblast cells. Mol. Cell. Biol. 8, 1670-1676.
7. 125I-labeled cationized monoclonal antibody against β-amyloid in mouse and dog. Drug Deliv. 2, 128-135.
8. Pardridge, W. M., Kang, Y.-S., Yang, J., and Buciak, J. L. (1995) Enhanced cellular uptake and in vivo biodistribution of a monoclonal antibody following cationization. J. Pharm. Sci. 84, 943-948.
9. Pardridge, W. M., Buciak, J., Yang, J., and Wu, D. (1998) Enhanced endocytosis in cultured human breast carcinoma cells and in vivo biodistribution in rats of a humanized monoclonal antibody following cationization of the protein. J. Pharmacol. Exp. Ther. 286, 548-554.
10. Pardridge, W. M., Bickel, U., Buciak, J., Yang, J., Diagne, A., and Aepinus, C. (1994) Cationization of a monoclonal antibody to the human immunodeficiency virus rev protein enhances cellular uptake but does not impair antigen binding of the antibody. Immunol. Lett. 42, 191-195.
11. Hong, G., Bazin-Redureau, M. I., and Scherrmann, J. M. G. (1999) Pharmacokinetics and organ distribution of cationized colchicine-specific IgG and Fab fragments in rat. J. Pharm. Sci. 88, 147-153.
12. 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors. Bioconjugate Chem. 10, 502-511.
13. Nicholson, R. I., Gee, J. M. W., and Harper, M. E. (2001) EGFR and cancer prognosis. Eur. J. Cancer 37, S9-S15.
14. Kurihara, A. and Pardridge, W. M. (1999) Imaging brain tumors by targeting peptide radiopharmaceuticals through the blood-brain barrier. Cancer Res. 54, 6159-6163.
15. Skarlatos, S. and Pardridge, W. M. (1995) Targeting of an anti-CR3 (CDllb/CD18) monoclonal antibody to spleen, but not brain, in vivo in mice. J. Drug Targeting 3, 9-14.
16. Pardridge, W. M., Kang, Y. S., Diagne, A., and Zack, J. A. (1996) Cationized hyperimmune immunoglobulins: Pharmacokinetics, toxicity evaluation, and treatment of HIV-infected scid-hu mice. J. Pharmacol. Exp. Ther. 276, 246-252.
17. Nucci, M. L., Shorr, R., and Abuchowski, A. (1991) The therapeutic value of poly(ethylene glycol)-modified proteins. Adv. Drug Deliv. Rev. 6, 133-151.